Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
2001 1
2004 2
2005 1
2007 1
2008 6
2009 5
2010 1
2011 4
2012 4
2013 5
2014 7
2015 16
2016 15
2017 16
2018 16
2019 11
2020 15
2021 23
2022 23
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Showing results for natalie large
Your search for Natalie LaRoe retrieved no results
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial.
Hutchings M, Morschhauser F, Iacoboni G, Carlo-Stella C, Offner FC, Sureda A, Salles G, Martínez-Lopez J, Crump M, Thomas DN, Morcos PN, Ferlini C, Bröske AE, Belousov A, Bacac M, Dimier N, Carlile DJ, Lundberg L, Perez-Callejo D, Umaña P, Moore T, Weisser M, Dickinson MJ. Hutchings M, et al. J Clin Oncol. 2021 Jun 20;39(18):1959-1970. doi: 10.1200/JCO.20.03175. Epub 2021 Mar 19. J Clin Oncol. 2021. PMID: 33739857 Free PMC article. Clinical Trial.
This trial included heavily pretreated patients with R/R B-NHL; most were refractory to prior therapy (155; 90.6%) and had received a median of three prior therapies. One hundred and twenty-seven patients (74.3%) had diffuse large B-cell lymphoma, transformed follicular ly …
This trial included heavily pretreated patients with R/R B-NHL; most were refractory to prior therapy (155; 90.6%) and had received a median …
Lipoprotein (a) and diabetes mellitus.
Lamina C, Ward NC. Lamina C, et al. Atherosclerosis. 2022 May;349:63-71. doi: 10.1016/j.atherosclerosis.2022.04.016. Atherosclerosis. 2022. PMID: 35606077 Review.
Although therapies that specifically target and lower Lp(a) have not been evaluated in diabetic patients, analysis of the large PCSK9 clinical outcomes trials suggest they are beneficial on cardiovascular outcomes....
Although therapies that specifically target and lower Lp(a) have not been evaluated in diabetic patients, analysis of the large PCSK9 …
25th Annual Computational Neuroscience Meeting: CNS-2016.
Sharpee TO, Destexhe A, Kawato M, Sekulić V, Skinner FK, Wójcik DK, Chintaluri C, Cserpán D, Somogyvári Z, Kim JK, Kilpatrick ZP, Bennett MR, Josić K, Elices I, Arroyo D, Levi R, Rodriguez FB, Varona P, Hwang E, Kim B, Han HB, Kim T, McKenna JT, Brown RE, McCarley RW, Choi JH, Rankin J, Popp PO, Rinzel J, Tabas A, Rupp A, Balaguer-Ballester E, Maturana MI, Grayden DB, Cloherty SL, Kameneva T, Ibbotson MR, Meffin H, Koren V, Lochmann T, Dragoi V, Obermayer K, Psarrou M, Schilstra M, Davey N, Torben-Nielsen B, Steuber V, Ju H, Yu J, Hines ML, Chen L, Yu Y, Kim J, Leahy W, Shlizerman E, Birgiolas J, Gerkin RC, Crook SM, Viriyopase A, Memmesheimer RM, Gielen S, Dabaghian Y, DeVito J, Perotti L, Kim AJ, Fenk LM, Cheng C, Maimon G, Zhao C, Widmer Y, Sprecher S, Senn W, Halnes G, Mäki-Marttunen T, Keller D, Pettersen KH, Andreassen OA, Einevoll GT, Yamada Y, Steyn-Ross ML, Alistair Steyn-Ross D, Mejias JF, Murray JD, Kennedy H, Wang XJ, Kruscha A, Grewe J, Benda J, Lindner B, Badel L, Ohta K, Tsuchimoto Y, Kazama H, Kahng B, Tam ND, Pollonini L, Zouridakis G, Soh J, Kim D, Yoo M, Palmer SE, Culmone V, Bojak I, Ferrario A, Merrison-Hort R, Borisyuk R, Kim CS, Tezuka T, Joo P, Rho YA, Burt… See abstract for full author list ➔ Sharpee TO, et al. BMC Neurosci. 2016 Aug 18;17 Suppl 1(Suppl 1):54. doi: 10.1186/s12868-016-0283-6. BMC Neurosci. 2016. PMID: 27534393 Free PMC article.
Steyn-Ross, D. Alistair Steyn-Ross O18 Modeling large-scale cortical networks with laminar structure Jorge F. Mejias, John D. ...Kleberg, Jochen Triesch P45 Simulation of EMG recording from hand muscle due to TMS of motor cortex Bahar Moezzi, Nicolangelo Iannella, Natal …
Steyn-Ross, D. Alistair Steyn-Ross O18 Modeling large-scale cortical networks with laminar structure Jorge F. Mejias, John D. ...Kleb …
Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O, Peter JU. Beth-Tasdogan NH, et al. Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866376 Review.
There is insufficient evidence to either claim or refute a benefit of the interventions tested for prophylaxis of MRONJ in patients with antiresorptive therapy undergoing dentoalveolar surgery. Although some interventions suggested a potential large effect, the studies wer …
There is insufficient evidence to either claim or refute a benefit of the interventions tested for prophylaxis of MRONJ in patients with ant …
Large airway complications in COVID-19 pneumonia.
May J, Ramos-Bascon N, Barnes N, Madden B. May J, et al. Monaldi Arch Chest Dis. 2021 Jul 22;92(1). doi: 10.4081/monaldi.2021.1894. Monaldi Arch Chest Dis. 2021. PMID: 34296836 Free article.
However the inflammatory nature of the condition and the interventions necessary to manage these patients such as endotracheal intubation and tracheostomy can lead to large airway pathology which may go unrecognised. We describe five of the 44 (11%) consecutive patients re …
However the inflammatory nature of the condition and the interventions necessary to manage these patients such as endotracheal intubation an …
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts.
Martin P, Cohen JB, Wang M, Kumar A, Hill B, Villa D, Switchenko JM, Kahl B, Maddocks K, Grover NS, Qi K, Parisi L, Daly K, Zhu A, Salles G. Martin P, et al. J Clin Oncol. 2023 Jan 20;41(3):541-554. doi: 10.1200/JCO.21.02698. Epub 2022 Jun 28. J Clin Oncol. 2023. PMID: 35763708 Free PMC article.
The efficacy findings were consistent in the validation cohort. CONCLUSION: In this large cohort of patients treated primarily in the US community setting, only one in four young patients received cytarabine or ASCT consolidation, suggesting the need to develop treatments …
The efficacy findings were consistent in the validation cohort. CONCLUSION: In this large cohort of patients treated primarily in the …
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.
Sivapiragasam A, Ashok Kumar P, Sokol ES, Albacker LA, Killian JK, Ramkissoon SH, Huang RSP, Severson EA, Brown CA, Danziger N, McGregor K, Ross JS. Sivapiragasam A, et al. Cancer Med. 2021 Jan;10(1):53-61. doi: 10.1002/cam4.3550. Epub 2020 Dec 12. Cancer Med. 2021. PMID: 33314633 Free PMC article.
We examined a large dataset of female metastatic breast cancers (MBCs) profiled with comprehensive genomic profiling (CGP) to identify the prevalence and distribution of immunotherapy responsiveness-associated biomarkers. ...
We examined a large dataset of female metastatic breast cancers (MBCs) profiled with comprehensive genomic profiling (CGP) to identif …
Psychological and pharmacological interventions for depression in patients with coronary artery disease.
Tully PJ, Ang SY, Lee EJ, Bendig E, Bauereiß N, Bengel J, Baumeister H. Tully PJ, et al. Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4. Cochrane Database Syst Rev. 2021. PMID: 34910821 Free PMC article. Review.
Pharmacological interventions probably result in a moderate to large increase in depression remission (OR 2.06, 95% CI 1.47 to 2.89, I(2) = 0%; moderate certainty evidence; 4 trials; n = 646). ...There was also low certainty evidence that pharmacological interventions may …
Pharmacological interventions probably result in a moderate to large increase in depression remission (OR 2.06, 95% CI 1.47 to 2.89, …
A large annular scaly plaque.
Wong GN, Li J, Mohamed M, Williams R, Chong A. Wong GN, et al. Aust J Gen Pract. 2018 Nov;47(11):783-784. doi: 10.31128/AJGP-04-18-4548. Aust J Gen Pract. 2018. PMID: 31207676 Free article. No abstract available.
Genetic ataxias: update on classification and diagnostic approaches.
Witek N, Hawkins J, Hall D. Witek N, et al. Curr Neurol Neurosci Rep. 2021 Feb 26;21(3):13. doi: 10.1007/s11910-021-01092-4. Curr Neurol Neurosci Rep. 2021. PMID: 33638050 Review.
Ataxia encompasses a large group of rare disorders characterized by irregular movements, decreased coordination, imbalance, kinetic tremor, wide-based stance, and dysarthria. ...
Ataxia encompasses a large group of rare disorders characterized by irregular movements, decreased coordination, imbalance, kinetic t …
160 results